The level of HER2/neu gene amplification as predictive factor in patients with metastatic breast cancer treated with a trastuzumab-based therapy
G. Gullo, D. Bettio, V. Torri, G. Masci, P. Salvini, A. SantoroVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70899-1
File:
PDF, 59 KB
english, 2008